Category: Boston

Chiasma Secures $5,115,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f2f54c2-33f3-465e-ba63-ccfac24598c7&Preview=1 Date 7/1/2011 Company Name Chiasma Mailing Address 831 Beacon St. Newton Center, MA 02459 Company Description Chiasma develops innovative solutions for the non-invasive delivery of protein drugs. Chiasma’s technology enables drugs to be administered into the bloodstream without the need for injections. Website http://www.chiasmapharma.com Transaction Type Venture Equity Transaction Amount $5,115,000 … Continue reading “Chiasma Secures $5,115,000 New Financing Round”

Olympus Medical Acquires Spirus Medical for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=33977166-7e07-4ee6-ab04-53026b790f4a&Preview=1 Date 7/1/2011 Company Name Spirus Medical Mailing Address 375 West Street West Bridgewater, MA 02379 Company Description Spirus Medical, Inc., headquartered in Stoughton, Mass., was incubated and founded in 2005 by STD Med, Inc., a Stoughton-based manufacturer and developer of medical technologies. Spirus has developed a revolutionary Endoluminal Advancement System (EAS(TM)) … Continue reading “Olympus Medical Acquires Spirus Medical for Undisclosed Sum”

IBM Is Looking to Buy-Is EMC in Its Crosshairs?

Big Blue celebrated 100 years of success in the tech industry earlier this month. It’s a rare feat in an industry where companies are often rendered obsolete in a decade, oftentimes sooner. In fact, IBM has managed to stay relevant while literally thousands of tech companies have come and gone. So, what’s its secret recipe? … Continue reading “IBM Is Looking to Buy-Is EMC in Its Crosshairs?”

Yottaa and SiteSpect Find Ways to Make Money by Making Websites Faster, More Targeted

These are two startups that aren’t household names in the Boston-area tech scene, but probably should be. One started in 2009, raised venture capital when it was tough to get in the downturn, and is currently adding new features and generating some buzz. The other started five years earlier, in 2004, bootstrapped itself to profitability, … Continue reading “Yottaa and SiteSpect Find Ways to Make Money by Making Websites Faster, More Targeted”

Lotus Pioneers New Treatment for Rare and Disfiguring Disorder, Raises $26 Million From Third Rock

Today marks the debut of Lotus Tissue Repair, a Cambridge, MA-based company that’s developing a treatment for a rare, genetic disease called dystrophic epidermolysis bullosa (DEB). The disease may not be well known, but the folks behind the startup certainly are. Lotus has closed a $26 million Series A financing round led by Boston-based Third … Continue reading “Lotus Pioneers New Treatment for Rare and Disfiguring Disorder, Raises $26 Million From Third Rock”

This Drug Didn’t Work for Me. May I Have My $88,000 Back, Please?

If you bought a new toaster, carried it home, plugged it in, and it didn’t work, what would you do? Suppose you purchased a pineapple at the grocery store, sliced it open, and found it was inedible. In both cases you’d seek the same remedy: you’d return the item and ask for your money back. … Continue reading “This Drug Didn’t Work for Me. May I Have My $88,000 Back, Please?”

Lotus Tissue Repair Lands $26,000,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=631e92cc-2f10-4659-bf91-4c2bc43bcd75&Preview=1 Date 6/30/2011 Company Name Lotus Tissue Repair Mailing Address One Mifflin Place Cambridge, MA 02138 Company Description Lotus Tissue Repair is developing its proprietary recombinant human collagen Type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such … Continue reading “Lotus Tissue Repair Lands $26,000,000 Series A Financing Round”

Acetylon, Backed by Patriots Owner Bob Kraft, Snags $27M to Develop New Cancer Drugs

Boston-based Acetylon Pharmaceuticals has been pursuing one of the hottest fields in cancer biology the past couple years, and today it said it was able to scrape together a sizable amount of money to execute on its game plan. The company, founded two years ago on scientific work at Harvard University and the Dana-Farber Cancer … Continue reading “Acetylon, Backed by Patriots Owner Bob Kraft, Snags $27M to Develop New Cancer Drugs”

My Lunch with Andy Ory: Acme Packet CEO Talks Startup Lessons, Growing Pains, and Building the Next Great Boston Company

It’s not every day I get to dine with the CEO of a public company worth $5 billion. Last month I sat down with Andy Ory, founder and chief exec at Bedford, MA-based Acme Packet (NASDAQ: [[ticker:APKT]]), for an in-depth chat about his company’s strategy and outlook in the area of networking technology. The setting … Continue reading “My Lunch with Andy Ory: Acme Packet CEO Talks Startup Lessons, Growing Pains, and Building the Next Great Boston Company”

IBM SmartCamp Makes Its Debut in New York, Attracts Startups From Across the Atlantic

[Updated 6/30/11. See below] Eager entrepreneurs armed with ideas they believe can improve our way of life gathered on Tuesday for the first ever New York edition of the IBM Global Entrepreneur SmartCamp. The competition, which came to Boston last June, brings select groups of startups together with mentors from the investor community. Deborah Magid, … Continue reading “IBM SmartCamp Makes Its Debut in New York, Attracts Startups From Across the Atlantic”

Genentech Buys Rights to Forma Drug, Nimbus Gets $24M, Lilliputian Adds $11M, & More Boston-Area Deals News

Companies in the health IT, electronics, and biotech spaces have all been making deals headlines this week. —Wilmington, MA-based Lilliputian Systems, a maker of tiny fuel cells for powering cell phones and laptops, took in $11.1 million of a targeted $21 million equity- and rights-based financing from 14 investors, according to an SEC filing. —Vigix, … Continue reading “Genentech Buys Rights to Forma Drug, Nimbus Gets $24M, Lilliputian Adds $11M, & More Boston-Area Deals News”

Acetylon Pharmaceuticals Receives $14,600,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b0f2ed69-9501-4125-bfb5-5f8063b45d5c&Preview=1 Date 6/29/2011 Company Name Acetylon Pharmaceuticals Mailing Address 303 Congress Street 2nd Fl Boston, MA 02210 Company Description Acetylon Pharmaceuticals is a Boston-based company recently formed to commercialize promising pharmaceutical technology emerging from collaborative research at Harvard University and the Dana-Farber Cancer Institute. Acetylon intends to pursue the clinical development and … Continue reading “Acetylon Pharmaceuticals Receives $14,600,000 Series B Round”

CyberSettle Lands $2,130,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=55816a68-ca76-4593-b9ca-29b34cfcda9d&Preview=1 Date 6/29/2011 Company Name CyberSettle Mailing Address 1700 East Putnum Avenue Old Greenwich, CT 06870 Company Description Cybersettle is the world leader in accelerated dispute resolution. We pioneered and hold patent rights to the automated, online, double-blind bid, dispute resolution system, which allows our clients to resolve a wide range of … Continue reading “CyberSettle Lands $2,130,000 New Financing”

Eliza Adds Financing From Parthenon

Beverly, MA-based Eliza, a developer of speech recognition technology for communicating healthcare information to patients, has taken in a growth investment from Parthenon Capital Partners, a Boston- and San Francisco-based private equity firm. The total of the investment was not disclosed, but it marks the first time Eliza has received institutional funding since founding in … Continue reading “Eliza Adds Financing From Parthenon”

Curis and Genentech Unleash the Hedgehog to Fight a Deadly Skin Cancer

Curis was founded in Lexington, MA, in 2000 with the intention of exploiting a disease-causing mechanism curiously named the hedgehog signaling pathway. Three years later, the startup attracted the attention of biotech pioneer Genentech, whose scientists believed hedgehog might offer a brand new way to fight cancer. Now the development deal that the two companies … Continue reading “Curis and Genentech Unleash the Hedgehog to Fight a Deadly Skin Cancer”

InfraReDx Nabs $24.1M

Burlington, MA-based medical device developer InfraReDx announced today that it had raised $24.1 million in an equity offering it sold to existing investors. The money will go to ongoing and new clinical trials exploring additional applications of its LipiScan IVUS coronary imaging system, which combines near infrared light and a type of intravascular ultrasound to … Continue reading “InfraReDx Nabs $24.1M”

MC10 Stretches for $12.5M More

Cambridge, MA-based MC10, a startup focused on designing electronics that can bend and stretch with the natural world, said today it has raised $12.5 million in Series B financing led by new investor Braemar Energy Ventures. Previous investors North Bridge Venture Partners, Osage University Partners, and Terawatt Ventures also participated in the round. MC10 is … Continue reading “MC10 Stretches for $12.5M More”

Xconomy’s New York Team Doubles in Size, Plots East Coast (Biotech) Takeover

It’s easy to forget that Arlene Weintraub, Xconomy New York’s editor, has been running a one-woman show since joining us in April. Sure she’s had loads of help from her colleagues across the Xconomy network. But still, the whole of New York tech and life sciences is a big monster of a beat for one … Continue reading “Xconomy’s New York Team Doubles in Size, Plots East Coast (Biotech) Takeover”

How to Innovate in a Hypersocial World: Q&A with Gail Goodman, CEO of Constant Contact

Constant Contact is a digital marketing company led by babes. I don’t mean women, though that is true, actually. And I don’t mean babies in the crying, needy, or naïve sense, but rather the youngest-in-the-family sense. Let me start over. As it turns out, many of the senior management team of Waltham, MA-based Constant Contact … Continue reading “How to Innovate in a Hypersocial World: Q&A with Gail Goodman, CEO of Constant Contact”

Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery

Nimbus Discovery burst out of stealth mode in March with seed funding from none other than Microsoft chairman Bill Gates. Now Nimbus, a Cambridge, MA-based company that specializes in computer-aided drug discovery, is chalking up a second impressive milestone: It has raised a Series A funding round of $24 million, with money from Gates and … Continue reading “Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery”

MC10 Lands $12,500,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5854f632-0433-4787-ab85-00e278780052&Preview=1 Date 6/28/2011 Company Name MC10 Mailing Address 36 Cameron Avenue Cambridge, MA 02140 Company Description MC10 startup developing stretchable silicon technology developed at the University of Illinois. Website http://www.mc10inc.com Transaction Type Venture Equity Transaction Amount $12,500,000 Transaction Round Series B Proceeds Purposes The company will use the funding to accelerate development … Continue reading “MC10 Lands $12,500,000 Series B Financing”

Nimbus Discovery Obtains $24,000,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f73bbff3-5e1e-4d1e-825d-2f07f8ab53f6&Preview=1 Date 6/28/2011 Company Name Nimbus Discovery Mailing Address 25 First Street Cambridge, MA 02141 Company Description Nimbus Discovery is applying advances in computer-based drug discovery to unlock fundamental biological pathways. Nimbus has already delivered selective, potent, and differentiated compounds within the first year for two disease targets, IRAK4 and ACC, which … Continue reading “Nimbus Discovery Obtains $24,000,000 Series A Funding Round”

InfraReDx Lands $24,100,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6db59204-0b0b-4886-ab99-a7ba1b50f156&Preview=1 Date 6/28/2011 Company Name InfraReDx Mailing Address 34 Third Avenue Burlington, MA 01803 Company Description The company has now developed a fiber-optic, catheter-based, near infrared (NIR) spectroscopy system designed to characterize the composition of coronary plaques in patients undergoing catheterization. This NIR system is currently being evaluated in a clinical study. … Continue reading “InfraReDx Lands $24,100,000 New Financing”

Lost In Translation: Ford Teams With Nuance Communications To Master Human Language

“Call John Smith.” “I wanna call John Smith.” At first glance, these sentences look pretty similar. But try telling that to the voice recognition technology behind Ford Motor’s SYNC system. You might as well be speaking Greek. Voices recognition software has come a long way in recent years. Google’s Android platform, for example, allows users … Continue reading “Lost In Translation: Ford Teams With Nuance Communications To Master Human Language”

Betting That Biotech Will Bring the FDA to Heel? Don’t Count On It

When Minnesota Democrat Al Franken and Massachusetts Republican Scott Brown line up on the same side of an issue, my first guess would usually be that it’s to vote on some meaningless resolution in favor of apple pie. Or, like now, it could be a sign that a controversial, potentially transformative piece of legislation is … Continue reading “Betting That Biotech Will Bring the FDA to Heel? Don’t Count On It”

Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal

Genentech doesn’t acquire many drugs from other people, partly because it has a prolific internal R&D operation. But the South San Francisco-based unit of Roche, the world’s biggest maker of cancer treatments, is announcing an unusual deal today in which it is paying to get an early-stage cancer drug program from Cambridge, MA-based Forma Therapeutics … Continue reading “Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal”

Black Duck Adds Jobs, Sees Transition to Helping Software Developers Use Open Source Tools

Black Duck Software CEO Tim Yeaton says his Waltham, MA-based company is fulfilling a mission that it set out on when he started two and a half years ago. “We enable organizations that are building software products and applications to use open source components successfully in their development,” Yeaton says. Black Duck was initially known … Continue reading “Black Duck Adds Jobs, Sees Transition to Helping Software Developers Use Open Source Tools”

SensAble Technologies Lands $740,853 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b118808-b1dc-4f68-b473-c462c1d1fcc0&Preview=1 Date 6/27/2011 Company Name SensAble Technologies Mailing Address 181 Ballardvale Street Wilmington, MA 01887 Company Description Founded in 1993, SensAble Technologies is a leading developer of 3D touch-enabled (force feedback) solutions and technology that allow users to not only see and hear an on-screen computer application, but to actually ‘feel’ it. … Continue reading “SensAble Technologies Lands $740,853 New Financing Round”

The Auto Magnate and the Scientist: How Mass General is Working With Lee Iacocca to Find a Diabetes Cure

What happens when a guy who got wealthy selling cars hands millions of dollars to a scientist and tells her how to spend it? Folks attending the American Diabetes Association conference starting today in San Diego are getting a hint of the answer to that question. Denise Faustman, director of the Massachusetts General Hospital (MGH) … Continue reading “The Auto Magnate and the Scientist: How Mass General is Working With Lee Iacocca to Find a Diabetes Cure”

Nuance Slaps Vlingo With False Advertising Lawsuit As Latest Move In Legal Battle

The patent litigation between Burlington, MA-based Nuance Communications (NASDAQ: [[ticker:NUAN]]) and Cambridge, MA-based Vlingo is nothing new. A false advertising lawsuit is, though. Earlier this week, Nuance filed such a lawsuit against Vlingo in Suffolk County Superior Court. The suit asserts that Vlingo, on its website and elsewhere, “makes numerous false and misleading representations of … Continue reading “Nuance Slaps Vlingo With False Advertising Lawsuit As Latest Move In Legal Battle”

Merck’s Julie Gerberding, Former CDC Director, on the Future of Vaccines

Not many pharmaceutical executives can say with a straight face that if they are successful, they will really help millions of people live significantly longer and healthier lives around the world. Julie Gerberding, the former director of the U.S. Centers for Disease Control and Prevention, has been in one of those rare positions for about … Continue reading “Merck’s Julie Gerberding, Former CDC Director, on the Future of Vaccines”

Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News

We didn’t bring you a life sciences roundup last Friday due to some time constraints, but some of the weeks’ headlines were too important to skip altogether. So here are two weeks worth of biotech profiles, partnership announcements, personnel moves, financing news, and more. —The American Chemical Society awarded its highest honor, the Priestley Medal, to … Continue reading “Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News”

NormOxys Obtains $1,556,353 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=78347d0d-3454-441b-b8f3-884b85a90a47&Preview=1 Date 6/24/2011 Company Name NormOxys Mailing Address 16 Laurel Ave. Wellesley, MA 02481 Company Description NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen deficiency. This new class of drugs can be potentially developed … Continue reading “NormOxys Obtains $1,556,353 New Round”

Vigix Raises $1.5M More, Looks to Reinvent Vending with Networked Kiosks

News flash: This company actually makes physical stuff for businesses. Not social software, not a mobile app or backend system, not a retail website or aggregator. And it has been able to raise some new money to expand its product. Its goal: to provide automated kiosks (see image, right) for dispensing everything from loyalty cards … Continue reading “Vigix Raises $1.5M More, Looks to Reinvent Vending with Networked Kiosks”

GE and VCs Invest $63M in 10 Cleantechs Through “Ecoimagination Challenge”

Fairfield, CT-based GE (NYSE: GE) and four venture capital partners said today they plan to invest a total of $63 million in 10 cleantech companies developing energy-related concepts in solar, communications and software, and building efficiency. The funding represents the second phase of a crowd-sourcing challenge, this time focused on “Powering Your Home,” that GE … Continue reading “GE and VCs Invest $63M in 10 Cleantechs Through “Ecoimagination Challenge””

XSITE 2011: The Entrepreneurship Era. First We Brought You Pictures, Now We Have A Video.

Xconomy editor Gregory Huang declared official recess for the heavy events season in Boston’s technology and startup communities. After a week that included WebInno, TechStars Demo Day, Angel Bootcamp, and an awesome all-day innovation forum, I’m not objecting. But we don’t want you to forget about this year’s installment of XSITE: The Xconomy Summit on … Continue reading “XSITE 2011: The Entrepreneurship Era. First We Brought You Pictures, Now We Have A Video.”

Vigix Lands $1,500,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=38870396-4a33-498f-b7e9-279a54276f15&Preview=1 Date 6/23/2011 Company Name Vigix Mailing Address 485 Massachusetts Avenue Waltham, MA 02139 Company Description VIGIX, Inc. provides turnkey kiosk networks to companies that want to create a highly efficient and direct channel to consumers. Website http://www.vigix.com Transaction Type Venture Equity Transaction Amount $1,500,000 Transaction Round Series A Proceeds Purposes Proceeds … Continue reading “Vigix Lands $1,500,000 Series A Financing Round”

Ringleadr Garners $500,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=41aa276f-e3f7-4f82-83c8-8b6edd99378e&Preview=1 Date 6/23/2011 Company Name Ringleadr Mailing Address 1 Faneuil Hall Market Pl Boston, MA 02109 Company Description Ringleadr is the first and only website that lets its users create the deals they want from the business that matter to them. Ringleadr is what daily deal websites were supposed to be; a … Continue reading “Ringleadr Garners $500,000 New Round”

Pixtronix Receives $4,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=be333f0f-1a57-4550-97bc-98d738f7e51f&Preview=1 Date 6/23/2011 Company Name Pixtronix Mailing Address 100 Burtt Road Andover, MA 01810 Company Description Pixtronix is an emerging display company developing portable display technology optimized specifically for mobile multimedia devices. The Pixtronix mission is to develop, manufacture, and market the world’s highest optical performance, lowest power consumption display modules. Website … Continue reading “Pixtronix Receives $4,000,000 New Funding”

Drupal Design Camp Boston

This third annual event is bringing together designers focused on the open source Drupal system. The two days will feature workshops and sessions on design, technology, and usability. Sign up here.

Braemar Energy Ventures Finds Value in Energy Technology, Both Clean and Conventional

During a panel discussion with three cleantech investors at the Energy Infotech Forum in New York City yesterday, an audience member posed a provocative question: “What won’t you invest in?” he asked. Scott DePasquale, a partner at Braemar Energy Ventures, responded “consumer space travel.” DePasquale was only half kidding. Ever since Braemar was founded in … Continue reading “Braemar Energy Ventures Finds Value in Energy Technology, Both Clean and Conventional”

XSITE 2011, TechStars Demo Day, the Bruins, and Coolio: 25 Things to Remember From Boston’s Hell Week

Ladies and gentlemen, after last week I hereby declare the end of high season for tech events in Boston. We’ve had our celebrations, drunk our grain, and talked our heads off. Now, before we start getting some things done around here, let’s reflect just a little more. The following took place during a 24-hour period … Continue reading “XSITE 2011, TechStars Demo Day, the Bruins, and Coolio: 25 Things to Remember From Boston’s Hell Week”

Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News

New England biotechs and IT startups don’t seem to indicate a summer slowdown. They’ve been inking some pretty massive financing deals this week, as well as an acquisition or two. —Cambridge, MA-based drug developer Aveo Pharmaceuticals (NASDAQ: [[ticker:AVEO]]) raised $100 million, selling 5.75 million shares of stock at $17.50 apiece in an underwritten public offering. … Continue reading “Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News”

Lilliputian Systems Receives $11,120,658 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f2a39ffd-c1f4-4ee6-a0b1-7f9d3083f27d&Preview=1 Date 6/22/2011 Company Name Lilliputian Systems Mailing Address 36 Jonspin Road Wilmington, MA 01887 Company Description Lilliputian has been rumored since 2001 to be developing a new kind of battery for electronic handheld devices and other applications. According to published reports, the company’s product is a combination of fuel cell and … Continue reading “Lilliputian Systems Receives $11,120,658 Series B Financing”

Kyruus Obtains $5,500,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ccf91279-46f7-4e9c-822d-d96c31dbdebb&Preview=1 Date 6/22/2011 Company Name Kyruus Mailing Address 374 Congress St. Boston, MA 02210 Company Description Kyruus has developed a software platform that includes professional profiles of doctors and “big data” analytics. Website http://www.kyruus.com Transaction Type Venture Equity Transaction Amount $5,500,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “Kyruus Obtains $5,500,000 Series A Funding Round”

Boston Technologies Receives $2,500,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=15773a05-25dd-4ca7-a9f7-bc25fb896d05&Preview=1 Date 6/22/2011 Company Name Boston Technologies Mailing Address 280 Summer Street 9th Floor Boston, MA 02210 Company Description Boston Technologies is an innovative leading provider of software, solutions, services and trading platforms to institutional and retail brokerage firms in the foreign exchange, CFD (contracts for difference), commodities, futures and options marketplace. … Continue reading “Boston Technologies Receives $2,500,000 New Financing”

VC Survey Highlights Anxiety Over Weak IPO Market

There must be some way out of here, but venture capitalists around the world say the current level of initial public offering (IPO) activity is too anemic to sustain the venture capital industry in the United States and eight other countries, according to a global VC survey. In the United States, 91 percent of the … Continue reading “VC Survey Highlights Anxiety Over Weak IPO Market”